Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingfei Granule for Pediatric Acute URTI with Bacterial Infection
NCT04479657Phase 1Unknown
- Start
- Oct 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Qingfei Granule in acute upper respiratory tract infection (URI) (2 arms). Primary endpoint: Bacterial clearance at Day 5. Status: unknown.
02
Drugs
Qingfei Granule
03
Conditions
acute upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT04479657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479657.